Cowen Healthcare Investments
55
84M
41
6.88
9
0.24
16
- Stages of investment
- Areas of investment
Summary
Cowen Healthcare Investments seemed to be an CVC arrangement as part of the organization.
The overall number of key employees were 2.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Orchard Therapeutics, Repare Therapeutics, KSQ Therapeutics. We can highlight the next thriving fund investment areas, such as Genetics, Therapeutics. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.
The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the Cowen Healthcare Investments, startups are often financed by Versant Ventures, F-Prime Capital, Slater Technology Fund. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Versant Ventures, RA Capital Management. In the next rounds fund is usually obtained by Innovate UK, Duchenne UK.
The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 50 - 100 millions dollars. The average startup value when the investment from Cowen Healthcare Investments is 50-100 millions dollars. The important activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this VC is 2 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Cowen Healthcare Investments performs on 7 percentage points less the average number of lead investments.
Investments analytics
Analytics
- Total investments
- 55
- Lead investments
- 9
- Exits
- 16
- Rounds per year
- 6.88
- Follow on index
- 0.24
- Investments by industry
- Biotechnology (47)
- Health Care (30)
- Therapeutics (21)
- Medical (19)
- Pharmaceutical (19) Show 12 more
- Investments by region
-
- United States (39)
- United Kingdom (8)
- Switzerland (4)
- Canada (1)
- Netherlands (1)
- Peak activity year
- 2020
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 46M
- Group Appearance index
- 0.98
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.35
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Lycia Therapeutics | 13 May 2024 | Biotechnology, Health Care, Life Science | Late Stage Venture | 106M | United States, California, San Diego |
| Neuron23 | 30 Mar 2022 | Health Care, Medical | Late Stage Venture | 100M | United States, California, San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.